Sichuan Cancer hospital. ( Site 1327)

Chengdu, Sichuan 610042

1 studies enrolling now · 1 studies all time

What they study most

Non Small Cell Lung Cancer

Studies at this site

• A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) — Recruiting now